Techfields Pharma Co., Ltd.
Records under this name other than the patents Techfields Pharma Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 11 patents it holds.
Back to Techfields Pharma Co., Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,479,527 | High Penetration Prodrug Compositions of Mustards and Mustard-Related Compounds Term ended Ended no later than Oct 3, 2026 · Medium confidence | Term ended | Ended no later than Oct 3, 2026 | Medium confidence |
| US 11,555,014 | High Penetration Prodrug Compositions of Prostaglandins and Related Compounds Term ended Term ended Oct 2, 2026 · High confidence | Term ended | Term ended Oct 2, 2026 | High confidence |
| US 9,872,846 | High penetration compositions and uses thereof Term ended Term ended Jul 9, 2026 · From the USPTO record | Term ended | Term ended Jul 9, 2026 | From the USPTO record |
| US 11,135,153 | High penetration composition and uses thereof Term ended Term ended Jul 9, 2026 · From the USPTO record | Term ended | Term ended Jul 9, 2026 | From the USPTO record |
| US 11,084,813 | Novel High Penetration Drugs and Their Compositions Thereof for Treatment of Parkinson Diseases Lapsed on the fee record Ended Aug 10, 2025 · High confidence | Lapsed on the fee record | Ended Aug 10, 2025 | High confidence |
| US 9,718,766 | Novel High Penetration Drugs and Their Compositions Thereof for Treatment of Parkinson Diseases Lapsed on the fee record Ended Aug 1, 2025 · High confidence | Lapsed on the fee record | Ended Aug 1, 2025 | High confidence |
| US 9,567,329 | High penetration prodrug compositions of 1H-imidazo[4,5-c]quinolin-4-amines and 1H-imidazo[4,5-c]quinolin-4-amine-related compounds and uses thereof Lapsed on the fee record Ended Feb 14, 2025 · From the USPTO record | Lapsed on the fee record | Ended Feb 14, 2025 | From the USPTO record |
| US 8,349,866 | High penetration prodrug compositions of 1H-imidazo[4,5-C]quinolin-4-amines and 1H-imidazo[4,5-C]quinolin-4-amine-related compounds Lapsed on the fee record Ended Jan 8, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jan 8, 2025 | From the USPTO record |
| US 10,233,197 | High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds Lapsed on the fee record Ended Mar 19, 2023 · From the USPTO record | Lapsed on the fee record | Ended Mar 19, 2023 | From the USPTO record |
| US 10,233,198 | Pro-drugs of NSAIAs with very high skin and membranes penetration rates and their new medicinal uses Lapsed on the fee record Ended Mar 19, 2023 · From the USPTO record | Lapsed on the fee record | Ended Mar 19, 2023 | From the USPTO record |